Search

everythinglearnresearchcommunity

for

Search:↓

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Some common medications can harm male fertility, but many effects can be reversed.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Belimumab effectively controls SLE disease activity and reduces steroid use.

A child with low platelets and anemia was later found to have lupus.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

Isotretinoin affects trace element levels and requires monitoring of liver and kidney functions.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Pranlukast and mirabegron may work as new diabetes drugs.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.